Comparative analysis of human papillomavirus detection by hybrid capture assay and routine cytologic screening to detect high-grade cervical lesions

International Journal of Cancer

Volumn 75, Issue 4, 1998, Pages 525-528

  Clavel, Christine ^a   Bory, Jean Paul ^a   Rihet, Stéphane ^a   Masure, Marie ^a   Duval Binninger, Isabelle ^a   Putaud, Isabelle ^a   Lorenzato, Marianne ^a   Quereux, Christian ^a   Birembaut, Philippe ^a  

^a REIMS UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER GRADING; CANCER SCREENING; CLINICAL PROTOCOL; COLPOSCOPY; CONTROLLED STUDY; FEMALE; HIGH RISK POPULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MOLECULAR HYBRIDIZATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PUNCH BIOPSY; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CONIZATION; UTERINE CERVIX CYTOLOGY; VIRUS DETECTION; WART VIRUS;

ADOLESCENT; ADULT; AGE FACTORS; AGED; CERVIX UTERI; DNA, VIRAL; FEMALE; HUMANS; MASS SCREENING; MIDDLE AGED; PAPILLOMAVIRIDAE; REAGENT KITS, DIAGNOSTIC; TUMOR VIRUS INFECTIONS; UTERINE CERVICAL DISEASES;

EID: 0032498592     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19980209)75:4<525::AID-IJC6>3.0.CO;2-V     Document Type: Article

References (27)

1. BOSCH, F.X., MANOS, M.M., Misoz, N., SHERMAN, M., JANSEN, A.M., PETO, J., SCHIFFMAN, M.H., MORENO, V., KLRMAN, R., SHAH, K.V. and THE INTERNATIONAL BIOLOGICAL STUDY IN CERVICAL CANCER STUDY GROUP, Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. J. nat. Cancer Inst., 87, 796-802 (1995).
2. BROWN, D.R., RAWLINOS, K., HANDY, V., FIFE, K.H., BRYAN, J.T., CRAMER, H. and GRAHAM, M., Human papillomavirus detection by hybrid capture in paired cervicovaginal lavage and cervical biopsy specimens. J. med. Virol., 48, 210-214 (1996).
3. COLE, H.M., Human papillomavirus DMA testing in the management of cervical neoplasia. J. Amer. med. Ass., 270, 2975-2981 (1993).
4. COX, J.T., LORINCZ, A.T., SCHIFFMAN, M.H., SHERMAN, M.E., CULLEN, A. and KURMAN, R.J., Human papillomavirus testing by hybrid capture appears to be useful in triaging women with a cytologic diagnosis of atypical squamous cells of undetermined significance. Amer. J. Obstet. Gynecol., 172, 946-954 (1995).
5. CUZICK, J., TERRY, G., Ho, L., HOLLINGWORTH, T. and ANDERSON, M., Human papillomavirus DNA in abnormal smears as a predictor of high-grade cervical intra-epithelial neopiasia. Brit. J. Cancer, 69, 167-171 (1994).
6. FARTHING, A., MASTERSON, P., MASON, W.P. and VOUSDEN, K.H., Human papillomavirus detection by hybrid capture and its possible clinical use. J. clin. Pathol., 47, 649-652 (1994).
7. FERENCZY, A., FRANCO, E., ARSENEAU, J., WRIGHT, T.C. and RICHART, R.M., Diagnostic performance of hybrid capture human papillomavirus deoxyribonucleic assay combined with liquid-based cytologic study. Amer. J. Obstet. Gynecol., 175, 651-656 (1996).
8. FIFE, K.H., KATZ, B.P., ROUSH, J., HANDY, V.D., BROWN, D.R. and HANSELL, R., Cancer-associated human papillomavirus types are selectively increased in the cervix of women in the first trimester of pregnancy. Amer. J. Obstet. Gynecol., 174, 1487-1493 (1996).
9. FUJINAGA, Y., SHIMADA, M., OKAZAWA, K., FUKUSHIMA, M., KATO, O. and FUJINAGA, K., Simultaneous detection and typing of genital human papillomavirus DNA using the polymerase chain reaction. J. gen. Virol., 72, 1039-1044 (1991).
10. GAARENSTROOM, K.N., MELKERT, P., WALBOOMERS, J.M.M., VAN DEN BRULE, A.J.C., VAN BOMMEL, P.F.J., MEIJER, C.J.L.M., VOORHORST, F.J., KENEMANS, P. and HELMERHORST, T.J.M., Human papillomavirus DNA genotypes: prognostic factors for progression of cervical intra-epithelial neoplasia. Int. J. gynecol. Cancer, 4, 73-78 (1994).
11. HATCH, K.D., SCHNEIDER, A. and ADDEL-NOUR, M.W., An evaluation of human papillomavirus testing for intermediate- and high-risk types as triage before colposcopy. Amer. J. Obstet. Gynecol., 172, 1150-1157 (1995).
12. Ho, G.Y.F., BURK, R.D., KLEIN, S., KADISH, A.S., CHANG, C.J., PALAN, P., BASU, J., TACHEZY, R., LEWIS, R. and ROMNEY, S., Persistent genital human papillomavirus infection as a risk factor for persistent cervical dyspiasia. J. nat. Cancer Inst., 87, 1365-71 (1995).
13. KAUFMAN, R.H., ADAM, E., ICENOGLE, J., LAWSON, H., LEE, N., REEVES, K.O., IRWIN, J., SIMON, T., PRRESS, M., UHLER, R., ENTMAN, C. and REEVES, W.C., Relevance of human papillomavirus screening in management of cervical intra-epithelial neopiasia. Amer. J. Obstet. Gynecol., 176, 87-92 (1997).
14. KOUTSKY, L.A., HOLMES, K.K., CRITCHLOW, C.W., STEVENS, C.E., PAAVONEN, J., BECKMANN, A.M., DEROUEN, T.A., GALLOWAY, D.A., VERNON, D. and KIIAT, N.B., A cohort study of the risk of cervical intra-epithelial neoplasia grade 2 or 3 in relation to papillomavirus infection. New Engl. J. Med., 327, 1272-1278 (1992).
15. LORINCZ, A.T., Hybrid capture method for detection of human papillomavirus DNA in clinical specimens. Papillomavirus Rep., 7, 1-5 (1996).
16. LORINCZ, A.T., REID, R., JENSON, A.B., GREENBERG, M.D., LANCASTER, W. and KURMAN, R.J., Human-papillomavirus infection of the cervix: relative-risk association of 15 common anogenital types. Obstet. Gynecol., 79, 328-337 (1992).
17. MELBYE, M., SMITH, E., WOHLFAHRT, J., OSTERLIND, A., ORHOLM, M., BERGMANN, O.J., MATHIESEN, L., DARRAGH, T.M. and PALEFSKY, J.M., Anal and cervical abnormality in women-prediction by human papillomavirus tests. Int. J. Cancer, 68, 559-564 (1996).
18. NINDL, I., ZAHM, D.M., MEIJER, C.J.L.M., WALBOOMERS, J.M.M. and SCHNEIDER, A., Human papillomavirus detection in high-grade squamous intra-epithelial lesions. Comparison of hybrid capture assay with a polymerase chain reaction system. Diagn. Microbiol. infect. Dis., 23, 161-164 (1995).
19. REMMINK, A.J., WALBOOMERS, J.M.M., HELMERHORST, T.J.M., VOORHORST, F.J., ROZKNDAL, L., RISSE, E.K.J., MEIJER, C.J.L.M. and KENEMANS, P., The presence of persistent high-risk HPV genotypes in dysplastic cervical lesions is associated with progressive disease: natural history up to 36 months. Int. J. Cancer, 61, 306-311 (1995).
20. RICHART, R.M. and WRIGHT, T.C., Controversies in the management of low-grade cervical intra-epithelial neoplasia. Cancer, 71, 1413-1421 (1993).
21. ROZENDAAL, L., WALBOOMERS, J.M.M., VAN DER LINDEN, J.C., VOORHORST, F.J., KENEMANS, P., HELMERHORST, T.J.M., VAN BALLEGOOIJEN, M. and MEIJER, C.J.L.M., PCR-based high-risk HPV test in cervical-cancer screening gives objective risk assessment of women with cytomorphologically normal cervical smears. Int. J. Cancer, 68, 766-769 (1996).
22. SCHIFFMAN, M.H. and 15 OTHERS, Accuracy and interlaboratory reliability of human papillomavirus DNA testing by hybrid capture. J. clin. Microbiol., 33, 545-550 (1995).
23. SCHNEIDER, A., ZAHM, D.M., KIRCHMAYR, R. and SCHNEIDER, V.L., Screening for cervical intra-epithelial neoplasia grade 2/3: validity of cytologic study, cervicography and human papillomavirus detection. Amer. J. Obstet. Gynecol., 174, 1534-1541 (1996).
24. SUN, X.W., FERENCZY, A., JOHNSON, D., KOULOS, J.P., JUNGU, O., RICHART, R.M. and WRIGHT, T.C., JR., Evaluation of the hybrid capture human papillomavirus deoxyribonucleic-acid detection test. Amer. J. Obstet. Gynecol., 173, 1432-1437 (1995).
25. VAN DEN BRULE, A.J.C., WALBOOMERS, J.M.M., Du MAINE, M., KENEMANS, P. and MEIJER, C.J.L.M., Difference in prevalence of human papillomavirus genotypes in cytomorphologically normal smears is associated with a history of cervical intra-epithelial neoplasia. Int. J. Cancer, 48, 404-408 (1991).
26. WALBOOMERS, J.M.M., DE RODA HUSMAN, A.M., SNIJDERS, P.J.F., STEL, H.V., RISSE, E.K.J., HELMERHORST, T.J.M., VOORHORST, F.J. and MEIJER, C.J.L.M., Detection of genital human papillomavirus infections. Critical review of methods and prevalence studies in relation to cervical cancer. In: P.L. Stern and M.A. Stanley (eds.), Human papillomaviruses and cervical cancer. Biology and immunology, pp. 41-71, Oxford University Press, Oxford (1994).
27. ZUR HAUSEN, H., Molecular pathogenesis of cancer of the cervix and its causation by specific human papillomavirus types. Curr. Top. Microbiol. Immunol. 186, 131-156 (1994).